https://www.selleckchem.com/pr....oducts/durvalumab.ht
idate genes. Future research could further define the role of common variants in survival outcomes for people with CAD and, ultimately, improve longitudinal outcomes for these patients. Replicated findings identified two candidate genes for further study regarding association with survival in high-risk CAD patients novel loci LINC01250 (rs13007553) and biologically relevant candidate DAB2IP (rs587936). These candidates did not overlap with validated longevity candidate genes. Future research could further define the role of common va
Like
Comment
Share
